Literature DB >> 11483527

Specific cleavage of hyper-edited dsRNAs.

A D Scadden1, C W Smith.   

Abstract

Extended double-stranded DNA (dsRNA) duplexes can be hyper-edited by adenosine deaminases that act on RNA (ADARs). Long uninterrupted dsRNA is relatively uncommon in cells, and is frequently associated with infection by DNA or RNA viruses. Moreover, extensive adenosine to inosine editing has been reported for various viruses. A number of cellular antiviral defence strategies are stimulated by dsRNA. An additional mechanism to remove dsRNA from cells may involve hyper-editing of dsRNA by ADARs, followed by targeted cleavage. We describe here a cytoplasmic endonuclease activity that specifically cleaves hyper-edited dsRNA. Cleavage occurs at specific sites consisting of alternating IU and UI base pairs. In contrast, unmodified dsRNA and even deaminated dsRNAs that contain four consecutive IU base pairs are not cleaved. Moreover, dsRNAs in which alternating IU and UI base pairs are replaced by isomorphic GU and UG base pairs are not cleaved. Thus, the cleavage of deaminated dsRNA appears to require an RNA structure that is unique to hyper-edited RNA, providing a molecular target for the disposal of hyper-edited viral RNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483527      PMCID: PMC149145          DOI: 10.1093/emboj/20.15.4243

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

Review 1.  The G x U wobble base pair. A fundamental building block of RNA structure crucial to RNA function in diverse biological systems.

Authors:  G Varani; W H McClain
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

Review 2.  On the wobble GoU and related pairs.

Authors:  B Masquida; E Westhof
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

Review 3.  Quality control of mRNA function.

Authors:  L E Maquat; G G Carmichael
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

4.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Identification of a functional mammalian spliceosome containing unspliced pre-mRNA.

Authors:  S M Abmayr; R Reed; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

Authors:  K A Lehmann; B L Bass
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

7.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

8.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase.

Authors:  C E Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  The yeast exosome and human PM-Scl are related complexes of 3' --> 5' exonucleases.

Authors:  C Allmang; E Petfalski; A Podtelejnikov; M Mann; D Tollervey; P Mitchell
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

10.  Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions.

Authors:  P J O'Hara; S T Nichol; F M Horodyski; J J Holland
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

View more
  54 in total

1.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

4.  Widespread RNA editing of embedded alu elements in the human transcriptome.

Authors:  Dennis D Y Kim; Thomas T Y Kim; Thomas Walsh; Yoshifumi Kobayashi; Tara C Matise; Steven Buyske; Abram Gabriel
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

5.  Pronounced instability of tandem IU base pairs in RNA.

Authors:  Martin J Serra; Patricia E Smolter; Eric Westhof
Journal:  Nucleic Acids Res       Date:  2004-03-22       Impact factor: 16.971

6.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  Sequestration and protection of double-stranded RNA by the betanodavirus b2 protein.

Authors:  Beau J Fenner; Winnie Goh; Jimmy Kwang
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 8.  Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms.

Authors:  Michal Lapidot; Yitzhak Pilpel
Journal:  EMBO Rep       Date:  2006-12       Impact factor: 8.807

9.  A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus.

Authors:  Roland C Zahn; Ina Schelp; Olaf Utermöhlen; Dorothee von Laer
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

10.  Regulation of Human Endonuclease V Activity and Relocalization to Cytoplasmic Stress Granules.

Authors:  Meh Sameen Nawaz; Erik Sebastian Vik; Natalia Berges; Cathrine Fladeby; Magnar Bjørås; Bjørn Dalhus; Ingrun Alseth
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.